Skip to content

Clinical trials

Phase 2/3 Inflammation trials with unknown status

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Inflammation Phase: Phase 2/3 Status: Unknown status Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20091
20111
20191
20202
20211
20221
20232
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
University of British Columbia2
University of Sao Paulo General Hospital2
Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia1
Biomedical Enterprises Inc1
Charite University, Berlin, Germany1
Montreal Heart Institute1
National Cheng-Kung University Hospital1
Shahid Beheshti University of Medical Sciences1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Inflammation11
Atherosclerosis2
Coronary Artery Disease2
Acne Vulgaris1
Amphetamine-Related Disorders1
Child Nutrition Disorders1
Dysbiosis1
HIV Infections1
Kidney Failure, Chronic1
Lipodystrophy1

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.